• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Wound Treatments in Italy Product Image

Wound Treatments in Italy

  • ID: 224755
  • March 2009
  • Region: Europe, Italy
  • 54 Pages
  • Euromonitor International

The Wound Treatments in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
- Get a detailed picture of the wound treatments industry
- Identify growth sectors and factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop

Wound Treatments in Italy
Euromonitor International
March 2009
List of Contents and Tables
Executive Summary
A Positive Result Driven by Price Liberalisation
the Weak Effects of Deregulation
A Fragmented Market Led by Bayer
Chemists/pharmacies Remain the Undisputed Leaders
Vitamins and Dietary Supplements Will Be Growth Driver
Key Trends and Developments
A Very Old Country
What Price? the Effects of Price Liberalisation
the Results of the New Bersani Law
Are Parapharmacies/drugstores True Competitors?
the Need for A Healthier Lifestyle
Pharmaclick - A New Distributor?
Market Data
Table 1 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 2 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 3 OTC Healthcare Company Shares by Value 2004-2008
Table 4 OTC Healthcare Brand Shares by Value 2005-2008
Table 5 Penetration of Private Label by Sector 2003-2008
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Waste
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventive Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
Definitions
Sources
Summary 2 Research Sources
A Menarini Industrie Farmaceutiche Riunite SRL
Strategic Direction
Key Facts
Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
Summary 4 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2008
Aziende Chimiche Riunite Angelini Francesco Acraf SpA
Strategic Direction
Key Facts
Summary 6 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts
Summary 7 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators
Company Background
Production
Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2007
Competitive Positioning
Summary 9 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2008
Bayer SpA
Strategic Direction
Key Facts
Summary 10 Bayer SpA: Key Facts
Summary 11 Bayer SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Bayer SpA: Competitive Position 2008
Bracco SpA
Strategic Direction
Key Facts
Summary 13 Bracco SpA: Key Facts
Summary 14 Bracco SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Bracco SpA: Competitive Position 2008
Chiesi Farmaceutici SpA
Strategic Direction
Key Facts
Summary 16 Chiesi Farmaceutici SpA: Key Facts
Summary 17 Chiesi Farmaceutici SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 18 Chiesi Farmaceutici SpA: Competitive Position 2008
Perfetti Van Melle SpA
Strategic Direction
Key Facts
Summary 19 Perfetti Van Melle SpA: Key Facts
Summary 20 Perfetti Van Melle SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 21 Perfetti Van Melle SpA: Competitive Position 2008
Recordati Industria Chimica E Farmaceutica SpA
Strategic Direction
Key Facts
Summary 22 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
Summary 23 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
Company Background
Production
Summary 24 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2007
Competitive Positioning
Summary 25 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2008
Sanofi-aventis SpA
Strategic Direction
Key Facts
Summary 26 Sanofi-Aventis SpA: Key Facts
Summary 27 Sanofi-Aventis SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 28 Sanofi-Aventis SpA: Competitive Position 2008
Sigma-tau Industrie Farmaceutiche Riunite SpA
Strategic Direction
Key Facts
Summary 29 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Key Facts
Summary 30 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 31 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2008
Zambon Italia SpA
Strategic Direction
Key Facts
Summary 32 Zambon Italia SpA: Key Facts
Summary 33 Zambon Italia SpA: Operational Indicators
Company Background
Production
Summary 34 Zambon Italia SpA: Production Statistics 2007
Competitive Positioning
Summary 35 Zambon Italia SpA: Competitive Position 2008
Headlines
Sector Data
Table 10 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 11 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 12 Wound Treatments Company Shares by Value 2004-2008
Table 13 Wound Treatments Brand Shares by Value 2005-2008
Table 14 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 15 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos